Evome Medical Technologies Inc.

TSXV:EVMT Stock Report

Market Cap: CA$11.2m

Evome Medical Technologies Balance Sheet Health

Financial Health criteria checks 2/6

Evome Medical Technologies has a total shareholder equity of CA$-2.4M and total debt of CA$14.0M, which brings its debt-to-equity ratio to -575.3%. Its total assets and total liabilities are CA$38.3M and CA$40.7M respectively.

Key information

-575.3%

Debt to equity ratio

CA$13.99m

Debt

Interest coverage ration/a
CashCA$1.07m
Equity-CA$2.43m
Total liabilitiesCA$40.69m
Total assetsCA$38.26m

Recent financial health updates

Here's Why We're Not Too Worried About Salona Global Medical Device's (CVE:SGMD) Cash Burn Situation

Jun 11
Here's Why We're Not Too Worried About Salona Global Medical Device's (CVE:SGMD) Cash Burn Situation

Recent updates

Here's Why We're Not Too Worried About Salona Global Medical Device's (CVE:SGMD) Cash Burn Situation

Jun 11
Here's Why We're Not Too Worried About Salona Global Medical Device's (CVE:SGMD) Cash Burn Situation

Financial Position Analysis

Short Term Liabilities: EVMT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: EVMT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: EVMT has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: EVMT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable EVMT has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: EVMT is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 39.9% per year.


Discover healthy companies